1、吉林省科学技术厅，重点研发，2020040405YY，一种治疗肺间质纤维化的院内制剂芪丹肺纤颗粒开发研究，2020-01至2022-12,30万元，结题，主持

2、国家自然科学基金委员会，青年科学基金项目，81804013，温肺补气通络方调控线粒体功能干预特发性肺间质纤维化分子机制研究，2019-01至2021-12，22万元，结题，主持

3、吉林省科学技术厅，自然科学基金，YDZJ202301ZYTS136，基于Mul1/Mfn2通路调控线粒体动力学-能量稳态的温肺补气通络方抗肺纤维化作用机制研究，2023.01至2025.12，10万元，在研，主持

1、A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection nd Perjeta® in healthy Chinese male subjects .EXPERT OPINION ON BIOLOGICAL THERAPY

2、Key regulators of intestinal stem cells: diet, microbiota, and microbial metabolites.JOURNAL OF GENETICS AND GENOMICS

3、The protective effects of baicalin for respiratory diseases: an update and future perspectives.FRONTIERS IN PHARMACOLOGY

4、Qimai Feiluoping decoction inhibits mitochondrial complex I-mediated oxidative stress to ameliorate bleomycin-induced pulmonary fibrosis.PHYTOMEDICINE

5、Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms.BIOMEDICINE & PHARMACOTHERAPY